Index of medicine substances

Paracetamol + pseudoephedrine + dextromethorphan  •  Respiratory system | Cough suppressants, excl. combinations with expectorants | Opium alkaloids and derivatives (R05DA20)

Paracetamol + pseudoephedrine + dextromethorphan + chlorpheniramine  •  Respiratory system | Cough suppressants, excl. combinations with expectorants | Opium alkaloids and derivatives (R05DA20)

Parathyroid hormone  •  Systemic hormonal preparations, excluding sex hormones and insulins | Parathyroid hormones and analogues (H05AA03)

Parecoxib  •  Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Coxibs (M01AH04)

Paricalcitol  •  Systemic hormonal preparations, excluding sex hormones and insulins | Anti-parathyroid agents | Other anti-parathyroid agents (H05BX02)

Paroxetine  •  Nervous system | Antidepressants | Selective serotonin reuptake inhibitors (N06AB05)

Pasireotide  •  Systemic hormonal preparations, excluding sex hormones and insulins | Hypothalamic hormones | Somatostatin and analogues (H01CB05)

Passion flower herb extract  •  ()

Passionflower  •  Nervous system | Hypnotics and sedatives | Other hypnotics and sedatives (N05CMN1)

Patiromer calcium  •  Various | All other therapeutic products | All other therapeutic products | Drugs for treatment of hyperkalemia and hyperphosphatemia (V03AE09)

Patisiran  •  Nervous system | Other nervous system drugs | Other nervous system drugs (N07XX12)

Pazopanib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors (L01EX03)

Pefloxacin  •  Antiinfectives for systemic use | Quinolone antibacterials | Fluoroquinolones (J01MA03)

Pegaptanib sodium  •  Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents (S01LA03)

Pegaspargase  •  Antineoplastic and immunomodulating agents | Other antineoplastic agents (L01XX24)

Pegcetacoplan  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Complement inhibitors (L04AJ03)

Pegfilgrastim  •  Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Colony stimulating factors (L03AA13)

Peginterferon alfa 2B  •  Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Interferons (L03AB10)

Peginterferon alfa-2A  •  Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Interferons (L03AB11)

Peginterferon beta-1A  •  Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Interferons (L03AB13)

Pegunigalsidase alfa  •  Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes (A16AB20)

Pegvisomant  •  Systemic hormonal preparations, excluding sex hormones and insulins | Anterior pituitary lobe hormones and analogues | Other anterior pituitary lobe hormones and analogues (H01AX01)

Pelargonium root extract  •  Respiratory system | Other respiratory system products | Other respiratory system products (R07AXN5)

Pembrolizumab  •  Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors (L01FF02)

Pemetrexeda  •  Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues (L01BA04)

Pemigatinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors (L01EX20)

Penicillamine  •  Musculo-skeletal system | Specific antirheumatic agents | Penicillamine and similar agents (M01CC01)

Pentaerythrityl tetranitrate  •  Cardiovascular system | Vasodilators used in cardiac diseases | Organic nitrates (C01DA05)

Pentazocine  •  Nervous system | Opioids | Benzomorphan derivatives (N02AD01)

Pentoxifylline  •  Cardiovascular system | Peripheral vasodilators | Peripheral vasodilators | Purine derivatives (C04AD03)